Cytokinetics, Incorporated Cytokinetics, Incorporated

Cytokinetics, Incorporated

CYTK

Rankning i aktier #2260
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on... Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
Aktiekurs
$64.11
Senast synkroniserad: 2026-10-20
Marknadsvärde
$8.91B
Förändring (1 dag)
2.34%
Förändring (1 år)
10.96%
Land
US
Handel Cytokinetics, Incorporated (CYTK)

Kategori

Healthcare
Historik för aktiesplit för Cytokinetics, Incorporated (CYTK)
Aktien Cytokinetics, Incorporated (symbol: CYTK) har genomgått totalt 1 aktiesplitar.
Den senaste spliten skedde den Jun 25, 2013.
En CYTK-aktie köpt före Jun 25, 2013 motsvarar nu 0.16666666666667 CYTK-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2013-06-25 1:6 x0.16666666666667 x0.16666666666667
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL